Literature DB >> 17826919

Matrix metalloproteinase-7 modulates synaptic vesicle recycling and induces atrophy of neuronal synapses.

A Szklarczyk1, K Conant, D F Owens, R Ravin, R D McKay, C Gerfen.   

Abstract

Matrix metalloproteinase-7 (MMP-7) belongs to a family of zinc dependent endopeptidases that are expressed in a variety of tissues including the brain. MMPs are known to be potent mediators of pericellular proteolysis and likely mediators of dynamic remodelling of neuronal connections. While an association between proteases and the neuronal synapse is emerging, a full understanding of this relationship is lacking. Here, we show that MMP-7 alters the structure and function of presynaptic terminals without affecting neuronal survival. Bath application of recombinant MMP-7 to cultured rat neurons induced long-lasting inhibition of vesicular recycling as measured by synaptotagmin 1 antibody uptake assays and FM4-64 optical imaging. MMP-7 application resulted in reduced abundance of vesicular and active zone proteins locally within synaptic terminals although their general levels remained unaltered. Finally, chronic application of the protease resulted in synaptic atrophy, including smaller terminals and fewer synaptic vesicles, as determined by electron microscopy. Together these results suggest that MMP-7 is a potent modulator of synaptic vesicle recycling and synaptic ultrastructure and that elevated levels of the enzyme, as may occur with brain inflammation, may adversely influence neurotransmission.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17826919     DOI: 10.1016/j.neuroscience.2007.07.032

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  13 in total

Review 1.  Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.

Authors:  M D Howell; P E Gottschall
Journal:  Neuroscience       Date:  2012-05-22       Impact factor: 3.590

Review 2.  Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine.

Authors:  Katherine Conant; Seung T Lim; Brad Randall; Kathleen A Maguire-Zeiss
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 3.  Implication of matrix metalloproteinases in regulating neuronal disorder.

Authors:  Abhishek Mukherjee; Snehasikta Swarnakar
Journal:  Mol Biol Rep       Date:  2015-01       Impact factor: 2.316

4.  Differential regulation of macrophage phenotype by mature and pro-nerve growth factor.

Authors:  Kimberly S Williams; Deirdre A Killebrew; Gillian P Clary; Jaimie A Seawell; Rick B Meeker
Journal:  J Neuroimmunol       Date:  2015-05-16       Impact factor: 3.478

Review 5.  Synaptic circuit remodelling by matrix metalloproteinases in health and disease.

Authors:  George W Huntley
Journal:  Nat Rev Neurosci       Date:  2012-10-10       Impact factor: 34.870

6.  Matrix metalloproteinase-dependent shedding of intercellular adhesion molecule-5 occurs with long-term potentiation.

Authors:  K Conant; Y Wang; A Szklarczyk; A Dudak; M P Mattson; S T Lim
Journal:  Neuroscience       Date:  2010-01-04       Impact factor: 3.590

7.  Two classes of matrix metalloproteinases reciprocally regulate synaptogenesis.

Authors:  Mary Lynn Dear; Neil Dani; William Parkinson; Scott Zhou; Kendal Broadie
Journal:  Development       Date:  2015-11-24       Impact factor: 6.868

8.  Secreted tissue inhibitor of matrix metalloproteinase restricts trans-synaptic signaling to coordinate synaptogenesis.

Authors:  Jarrod Shilts; Kendal Broadie
Journal:  J Cell Sci       Date:  2017-06-02       Impact factor: 5.285

9.  Matrix metalloproteinases, synaptic injury, and multiple sclerosis.

Authors:  Arek Szklarczyk; Katherine Conant
Journal:  Front Psychiatry       Date:  2010-10-05       Impact factor: 4.157

10.  Matrix metalloproteinases regulate the formation of dendritic spine head protrusions during chemically induced long-term potentiation.

Authors:  Zsuzsanna Szepesi; Monika Bijata; Blazej Ruszczycki; Leszek Kaczmarek; Jakub Wlodarczyk
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.